Cargando…
Human Calmodulin-Like Protein CALML3: A Novel Marker for Normal Oral Squamous Mucosa That Is Downregulated in Malignant Transformation
Oral cancer is often diagnosed only at advanced stages due to a lack of reliable disease markers. The purpose of this study was to determine if the epithelial-specific human calmodulin-like protein (CALML3) could be used as marker for the various phases of oral tumor progression. Immunohistochemical...
Autores principales: | Brooks, Michael D., Bennett, Richard D., Weaver, Amy L., Sebo, Thomas J., Eckert, Steven E., Strehler, Emanuel E., Carr, Alan B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723245/ https://www.ncbi.nlm.nih.gov/pubmed/23935623 http://dx.doi.org/10.1155/2013/592843 |
Ejemplares similares
-
Immunolocalization of the Tumor-Sensitive Calmodulin-Like Protein CALML3 in Normal Human Skin and Hyperproliferative Skin Disorders
por: Bennett, Richard D., et al.
Publicado: (2013) -
CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma
por: Kanamori, Koichiro, et al.
Publicado: (2023) -
CALML5 is a ZNF750- and TINCR-induced protein that binds stratifin to regulate epidermal differentiation
por: Sun, Bryan K., et al.
Publicado: (2015) -
Identification of lactylation gene CALML5 and its correlated lncRNAs in cutaneous melanoma by machine learning
por: Feng, Hailiang, et al.
Publicado: (2023) -
Histomorphometric analysis of vascularity in normal buccal mucosa, leukoplakia, and squamous cell carcinoma of buccal mucosa
por: Pujari, Ravi Kumar V, et al.
Publicado: (2013)